Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antiretroviral Therapy and Inflammatory and Coagulation Biomarkers: Establishment of a Prospective Cohort, iMACS Study

NCT02027480 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT02027480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02027480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antiretroviral Therapy and Inflammatory and Coagulation Biomarkers: Establishment of a Prospective Cohort, iMACS Study
Lead sponsor
Columbia University
Phase
Observational
Overall status
Completed
Start date
March 31, 2014
Completion date
October 31, 2015
Enrollment
685 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

aids (acquired immune deficiency syndrome), hiv (human immunodeficiency virus), non-communicable diseases (ncd), tuberculosis